Commentary: Depression and Risk of Dementia: Exploring the Interface
J Clin Psychiatry 2013;74(12):1262-1263
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
Neuropsychiatric symptoms have not been part of the defining diagnostic criteria of dementia or mild cognitive impairment (MCI), but their characterization and importance in the preclinical stages of Alzheimer’s disease and presentation of prodromal states such as MCI and potential conversion to dementia continue being established. Subjects progressing to dementia have a higher prevalence of psychopathology than those who remain stable or improve, and thus neuropsychiatric symptoms appear to be a predictor of progression to dementia alongside established factors such as apolipoprotein E (APOE) ε4 carrier status, features of memory function, cerebrospinal fluid Aβ/tau ratio, amyloid imaging, and magnetic resonance imaging volumetric measurements of the hippocampal formation.
Depression and cognitive disorders are the most common neuropsychiatric disorders in later life. Their co-occurrence most likely exceeds chance.